Beam Therapeutics Inc. (NASDAQ:BEAM) Q4 2025 Earnings Call Transcript February 24, 2026
Beam Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-1.13.
Operator: Good morning, and welcome to Beam Therapeutics Conference Call. [Operator Instructions] Please be advised that this call is being recorded at Beam’s request. I would now like to turn the call over to Holly Manning, Vice President of Investor Relations and External Communications. Please go...
